International Stem Cell Corp (ISCO)
0.09
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
International Stem Cell Total Liabilities (Quarterly): 9.577M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 9.577M |
| September 30, 2023 | 9.50M |
| June 30, 2023 | 9.632M |
| March 31, 2023 | 9.787M |
| December 31, 2022 | 9.655M |
| September 30, 2022 | 9.694M |
| June 30, 2022 | 9.834M |
| March 31, 2022 | 10.01M |
| December 31, 2021 | 9.534M |
| September 30, 2021 | 9.294M |
| June 30, 2021 | 9.921M |
| March 31, 2021 | 10.72M |
| December 31, 2020 | 9.62M |
| September 30, 2020 | 9.727M |
| June 30, 2020 | 10.39M |
| March 31, 2020 | 9.719M |
| December 31, 2019 | 9.508M |
| September 30, 2019 | 8.936M |
| June 30, 2019 | 9.732M |
| March 31, 2019 | 5.477M |
| December 31, 2018 | 5.259M |
| September 30, 2018 | 5.939M |
| June 30, 2018 | 6.773M |
| March 31, 2018 | 5.829M |
| December 31, 2017 | 4.80M |
| Date | Value |
|---|---|
| September 30, 2017 | 8.139M |
| June 30, 2017 | 6.021M |
| March 31, 2017 | 7.217M |
| December 31, 2016 | 3.601M |
| September 30, 2016 | 7.115M |
| June 30, 2016 | 8.843M |
| March 31, 2016 | 21.24M |
| December 31, 2015 | 5.544M |
| September 30, 2015 | 6.396M |
| June 30, 2015 | 6.08M |
| March 31, 2015 | 6.772M |
| December 31, 2014 | 6.858M |
| September 30, 2014 | 7.21M |
| June 30, 2014 | 6.98M |
| March 31, 2014 | 10.99M |
| December 31, 2013 | 11.96M |
| September 30, 2013 | 11.33M |
| June 30, 2013 | 7.517M |
| March 31, 2013 | 6.535M |
| December 31, 2012 | 7.128M |
| September 30, 2012 | 6.905M |
| June 30, 2012 | 7.27M |
| March 31, 2012 | 6.917M |
| December 31, 2011 | 2.114M |
| September 30, 2011 | 2.189M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
8.936M
Minimum
Sep 2019
10.72M
Maximum
Mar 2021
9.725M
Average
9.694M
Median
Sep 2022
Total Liabilities (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 9.147M |
| Perspective Therapeutics Inc | 48.40M |
| Protalix BioTherapeutics Inc | 60.04M |
| Electromed Inc | 6.357M |
| Armata Pharmaceuticals Inc | 176.87M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.39M |
| Shareholders Equity (Quarterly) | -4.187M |
| Debt to Equity Ratio | -0.8257 |
| Current Ratio | 0.7287 |
| Net Debt Paydown Yield | -6.69% |